EPO Patents = 3

Trademarks = 6

Forward Citations = 11

Loading Chart...

4 inventors (with patents filed for the assignee):

Mark Nidorf (14 out of 14 patents)

Susanne Riel (5 out of 5 patents)

Michael Riel (2 out of 2 patents)

4. Yosuf El-Shabrawi (1 out of 1 patent)

22 patents: Sort by Forward Citations

1. 12691072 - Sustained-release formulations of colchicine and methods of using same (2026-07-28),

2. 12364675 - Treatment or prevention of cardiovascular events via the administration of a colchicine derivative (2025-07-22),

3. 12280025 - Treatment or prevention of cardiovascular events via the administration of a colchicine derivative (2025-04-21),

4. 12233035 - Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent and statin (2025-02-25),

5. 11944595 - Treatment or prevention of cardiovascular events via the administration of a colchicine derivative (2024-04-02),

6. 11944594 - Treatment or prevention of cardiovascular events via the administration of a colchicine derivative (2024-04-02),

7. 11877991 - Use of colchicine to inhibit tumor growth and metastases (2024-01-23),

8. 11666545 - Treatment or prevention of cardiovascular events via the administration of a colchicine derivative (2023-06-06),

9. 11648206 - Sustained-release formulations of colchicine and methods of using same (2023-05-16),

10. 11534415 - Use of colchicine to inhibit tumor growth and metastases (2022-12-27),

11. 11026901 - Treatment or prevention of cardiovascular events via the administration of a colchicine derivative (2021-06-08),

12. 11026900 - Treatment or prevention of cardiovascular events via the administration of a colchicine derivative (2021-06-08),

13. 11026899 - Treatment or prevention of cardiovascular events via the administration of a colchicine derivative (2021-06-08),

14. 11000530 - Methods and compositions for the treatment of ophthalmic conditions (2021-05-11),

15. 10842762 - Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent (2020-11-24),

Company Overview

Murray and Poole Enterprises Limited is a Gibraltar-based company specializing in innovative solutions across various sectors. The organization focuses on developing advanced technologies and products that cater to diverse industries, including finance, logistics, and telecommunications. With a commitment to quality and excellence, the company leverages its expertise to create impactful solutions that enhance operational efficiency and drive growth in the markets it serves.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

22 Patents

#4 in Gibraltar

#28,782 in the World

Gibraltar, Gibraltar

Murray and Poole Enterprises Limited

Forward Citations = 11

4 inventors:

Mark Nidorf (14 out of 14 patents)

Susanne Riel (5 out of 5 patents)

Michael Riel (2 out of 2 patents)

4. Yosuf El-Shabrawi (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Murray and Poole Enterprises Limited. Retrieved from https://idiyas.com/company/murray-and-poole-enterprises

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]